| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101992786-B1 |
| titleOfInvention |
Method for providing information of prediction and diagnosis of obesity using methylation level of CYP2E1 gene and composition therefor |
| abstract |
The present invention relates to the use of CYP2E1 (Cytochrome P450 2E1) The present invention relates to a method and a kit for predicting or diagnosing obesity using the methylation level of a promoter region of a gene and a kit for predicting or diagnosing obesity. The CYP2E1 methylated biomarker according to the present invention not only predicts obesity, , Diagnosis of pathology, diagnosis of stage of disease, and selection of treatment targets. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102280575-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102314971-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102314972-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210039242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210039322-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102327508-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210096350-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210096351-A |
| priorityDate |
2017-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |